UTS2R

Across TCGA pan-cancer cohorts, UTS2R Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated UTS2R data layer compared with 25 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher UTS2R Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated UTS2R expression acts as an unfavorable survival marker.

STAD, SCLC, and GBM are the cancer types where UTS2R Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.250	0.689	.005	24	view →
SCLC	OS	Median	All	0.055	0.653	<.001	18	view →
GBM	OS	Median	All	0.089	0.413	.015	6	view →
LIHC	OS	Median	All	0.235	0.690	.013	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

UTS2R–STAD (OS)

Open the STAD breakdown →